Beckley Psytech
Beckley Psytech Limited
- HQ
- United Kingdom
- Registry
- Companies House · 11496099
- Status
- active
- Listing
- Private
- Current stage
- subsidiary within AtaiBeckley group
find-and-update.company-information.service.gov.ukregistryverified 2026-09-15
Notes on the record
Sponsor of record on all four BPL-003 ClinicalTrials.gov records and on CTIS 2024-513457-70-00. Companies House number not yet pulled; incorporation_registry and registry_id blank pending that check. Companies House 11496099, active, incorporated 2018-08-02, previous name Beckley Psychedelics Limited. Latest filings: CS01 confirmation statement filed 2026-08-27; RP01/AP01 replacement filing 2026-08-20 for the appointment of Dr Robert Hershberg as director; PSC05 filed 2026-06-29 records Atai Beckley N.V. as person with significant control. No filing dated on or after 2026-09-08 as of 2026-09-15, so no post-merger PSC change yet.
Assets
Phase 2b complete; company stated Phase 3 activities initiated (Q2 2026 10-Q); no Phase 3 record on ClinicalTrials.gov or CTIS as of 2026-09-15. Sweeps 2026-09-15: intervention BPL-003 OR mebufotenin OR VLS-01 with Phase 3 filter returns 0; sponsor Beckley Psytech 7 records, max Phase 2; sponsor atai Therapeutics 3, max Phase 2; sponsor AtaiBeckley 0; sponsor Eli Lilly with those interventions 0; CTIS BPL-003 1 record (2024-513457-70-00, Ended). NCT05870540 record updated 2026-09-10, status COMPLETED unchanged · treatment-resistant depression; separate Phase 2 in alcohol use disorder
clinicaltrials.govregistryverified 2026-09-15
Registered trials
PHASE1 · Pharmacokinetics in Healthy Adults · COMPLETED · United Kingdom
clinicaltrials.govctgov registryverified 2026-08-31
PHASE2 · Treatment Resistant Depression · RECRUITING · United Kingdom
clinicaltrials.govctgov registryverified 2026-08-31
PHASE2 · Alcohol Use Disorder · COMPLETED · United Kingdom
clinicaltrials.govctgov registryverified 2026-08-31
PHASE2 · Treatment Resistant Depression · COMPLETED · Australia, Germany, Poland, Spain, United Kingdom, United States
clinicaltrials.govctgov registryverified 2026-09-15
Therapeutic exploratory (Phase II) · Treatment-Resistant Depression (TRD) · Ended · Germany, Poland, Spain
euclinicaltrials.euctis registryverified 2026-08-31
Deals
atai Life Sciences N.V. (renamed Atai Beckley N.V. on completion) acquires Beckley Psytech Limited
acquisition · closed
sec.govsec filingverified 2026-08-26
In the briefing
3 issues tagged BECKLEY-PSYTECH.